Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05802069 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 1 word
  2. Re-verified, no change to tracked fieldsv5
  3. Primary and study completion dates: Dec 2033 to Dec 2027v4
  4. Site contact updatedv3
  5. Study Identification, Study Status, Contacts/Locationsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is an observational trial for patients undergoing cancer-related interventions and therapy at Medical College of Wisconsin Cancer Center. Projects under this protocol will use patient data that will be collected both retrospectively and prospectively. It will also enable prospective sample collection for specific cancer-related studies.
Trial Details
NCT Number NCT05802069
Lead Sponsor Sameem M. Abedin, MD
Conditions
(from sponsor)		 Cancer
Related terms Neoplasms
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov